The latest in life sciences

We look at hot topics in life sciences, from the investment and deal environment, to incoming Brexit-related rules for medical devices, targeted treatments, and patent pools as a facilitator of the longed-for COVID-19 vaccine.

2020年7月

6 观点

6 观点

How to prepare for the MHRA's new medical devices enforcement rules

Key actions you can take to prepare for the new enforcement rules.

更多
点击此处了解更多

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

An exploration of patent pools, R&D and current initiatives.

更多
点击此处了解更多

Placing medical devices on the UK market after the end of Brexit transition

Discussing incoming rules and MHRA guidance for placing medical devices on the market in Great Britain and Northern Ireland.

更多
点击此处了解更多

Private equity investment in life sciences sector

Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.

更多
点击此处了解更多

Targeted treatments – Part 4: patenting digital devices

Important advances are being driven by digital communications technology, particularly in the medical devices sector.

更多
点击此处了解更多

UK increases scrutiny of tech and life sciences deals

Mergers and acquisitions in the tech and life sciences sectors may be subject to closer scrutiny by the UK competition authority and by the UK government in future.

更多
点击此处了解更多

返回

Interface

前往 Interface主页